5-Amino-1MQ
- Home
- 5-Amino-1MQ
Contents
What is 5-Amino-1MQ?
5-Amino-1MQ is a small-molecule compound (not a peptide), developed as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy balance and metabolic regulation. By inhibiting NNMT, it is thought to preserve nicotinamide for NAD+ synthesis rather than conversion into methylated metabolites. It emerged from research into obesity and metabolic disorders. Unlike peptide-based agents, 5-amino-1MQ acts through targeted enzyme inhibition, with preclinical studies suggesting potential effects on fat metabolism, energy expenditure, and body composition.
What is 5-Amino-1MQ Used for?
Potential research applications of 5-Amino-1MQ amidate include:
- Weight management and obesity research
- Fat metabolism and fat cell function
- Regulating energy and caloric expenditure
- NAD+ metabolism and nicotinamide pathway research
Side Effects of 5-Amino-1MQ
5-Amino-1MQ has demonstrated a favorable safety profile in preclinical studies. It has generally been described as well tolerated over short study periods, without clear evidence of major toxicity at the doses evaluated. Reported effects have focused more on metabolic changes than on a consistent side-effect profile.
5-Amino-1MQ Dosing Protocol (for Research)
Because human clinical dosing has not been established, the following should be viewed as a translational research framework rather than a validated human regimen:
- 1Week 1: 0.5 - 1 mg daily
- 2Weeks 2-3: 2 mg daily
- 3Week 4 and beyond: Up to 5 mg daily
Recommended 5-Amino-1MQ Source (for Research)